Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Legend Biotech ADR | LEGN | Aug 30, 2024 | 57.55 | +1.48 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Aug 30, 2024 | 39.92 | +0.88 |
Leggett & Platt | LEG | Aug 30, 2024 | 12.64 | -0.39 |
Leidos | LDOS | Aug 30, 2024 | 158.51 | +0.68 |
LeMaitre Vascular | LMAT | Aug 30, 2024 | 90.29 | +1.88 |
Lemonade | LMND | Aug 30, 2024 | 18.53 | -0.22 |
LendingClub | LC | Aug 30, 2024 | 12.15 | +0.25 |
LendingTree | TREE | Aug 30, 2024 | 57.93 | +0.42 |
Lendway | LDWY | Aug 30, 2024 | 4.12 | -13.72 |
Lennar A | LEN | Aug 30, 2024 | 182.06 | +0.86 |
Lennar B | LEN-B | Aug 30, 2024 | 168.83 | +1.10 |
Lennox International | LII | Aug 30, 2024 | 590.19 | +2.66 |
LENSAR | LNSR | Aug 30, 2024 | 4.67 | +0.43 |
LENZ Therapeutics | LENZ | Aug 30, 2024 | 23.39 | +5.84 |
Leonardo DRS | DRS | Aug 30, 2024 | 28.54 | +0.88 |
Lesaka Technologies | LSAK | Aug 30, 2024 | 4.69 | -3.30 |
Leslies | LESL | Aug 30, 2024 | 3.02 | +20.80 |
Levi Strauss & Co A | LEVI | Aug 30, 2024 | 19.27 | +1.21 |
Lexaria Bioscience | LEXX | Aug 30, 2024 | 3.91 | +21.05 |
Lexeo Therapeutics | LXEO | Aug 30, 2024 | 11.51 | -0.95 |
Lexicon Pharmaceuticals | LXRX | Aug 30, 2024 | 1.73 | -3.89 |
LexinFintech ADR | LX | Aug 30, 2024 | 1.73 | +2.37 |
LG Display ADR | LPL | Aug 30, 2024 | 4.14 | +2.22 |
LGI Homes | LGIH | Aug 30, 2024 | 107.88 | +1.14 |
LGL Group | LGL | Aug 30, 2024 | 5.96 | +1.97 |
Li Auto ADR | LI | Aug 30, 2024 | 19.46 | -1.17 |
Li-Cycle | LICY | Aug 30, 2024 | 1.38 | -6.76 |
Liberty Allstar Equity Fund | USA | Aug 30, 2024 | 6.98 | +1.31 |
Liberty Allstar Growth Fund | ASG | Aug 30, 2024 | 5.48 | +0.55 |
Liberty Broadband A | LBRDA | Aug 30, 2024 | 61.25 | -1.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.